PRF1 and neoplasm: Remarkably, mice bearing B16-F10-B2m−/− lung tumors still benefited from IV BCG treatment in a perforin-dependent manner (Fig. 5d), showing that BCG-activated NK cells can eliminate tumor cells independently from CD8+ T cell activity via perforin-mediated cytotoxicity.